Category: Approval/Launch Region: Asia · Japan Company: Daiichi Sankyo Chemical Pharma Co Ltd

Daiichi Sankyo Seeks Japanese Approval For Valemetostat To Treat For Patients With Adult T-Cell Leukaemia/Lymphoma

Daiichi Sankyo Seeks Japanese Approval For Valemetostat To Treat For Patients With Adult T-Cell Leukaemia/Lymphoma
Daiichi Sankyo Company, Limited Announced That It Has Submitted A New Drug Application (Nda) To Japan

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!